(Reuters) -Lonza said on Friday Chairman Albert Baehny will step down in May after six years in the job, in a second senior management reshuffle in recent months as the Swiss contract drug ...

Lonza Group announced Monday morning that Pierre-Alain Ruffieux will leave his post as CEO at the end of the month. Ruffieux, a former Roche executive, joined Lonza in 2020 and oversaw the company’s ...

(Reuters) -Contract drug manufacturer Lonza said on Monday Chief Executive Pierre-Alain Ruffieux will leave the Swiss company by mutual agreement at the end of the month, weighing on investor ...

Lonza reported sales of 6.5 billion Swiss francs last year (about $8.5 billion in U.S. dollars) reflecting constant exchange rate (CER) sales growth of 21.7 percent, according to a release issued ...

Lonza officials say they have expanded the company’s service offering for orally delivered biologic therapies to support the unique development and manufacturing needs of smart capsule companies. Oral ...

Lonza launched its AI-enabled Route Scouting Service offering which is designed to streamline synthetic route identification for novel APIs by combining Lonza’s global chemical supply chain ...

In a move to expand its mammalian manufacturing, Swiss CDMO Lonza said it has purchased a clinical-stage site in Hayward, California, from Shire. The deal, announced this week, is for the ...

Lonza Group agreed to buy InterHealth Nutraceuticals of Benicia for as much as $300 million, a sign the Swiss chemical maker may be back on the hunt for major acquisitions after a break of almost five ...

Swiss CDMO powerhouse Lonza is on a roll. Right after revealing a manufacturing expansion set to create nearly 200 new jobs, the CDMO has unveiled an expanded collaboration with an unnamed “major ...